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The complement system, a set of 20 plasma proteins, is an effector of several
functions associatedwith inflammation, immunologicregulation, and cytotoxicity
(1). Two complement proteins, C2 ofthe classical pathway and factor B of the
alternative pathway, have many structural and functional similarities, including
amino acid composition, molecular size, electrophoretic mobility, and genetic
linkage to the MHC on the short arm of human chromosome 6 (2). The primary
site of synthesis of C2 and factor B is the liver, although synthesis of C2 and
factor B has also been detected in cells of the monocyte/macrophage lineage (3)
and in mouse L cells (C2 only) (4).
The synthesis of C2 and factor B in monocytes is regulated characteristically
by LPS and IFN-y. LPS, a constituent of cell walls of Gram-negative bacteria
and a potent activator ofhumoral and cellular immunity (5), stimulated 15-fold
more factor B than C2 synthesis, while IFN-y, an immunoregulator lymphokine,
stimulated approximately equal increases (6). Distinct effects of each substance
have been noted on other monocyte functions. Synergistic responses of combi-
nations of LPS and IFN-y have also been observed. One of the most widely
studied responses to these stimuli is tumor cell killing by macrophages, where
IFN-y increases the sensitivity of the macrophages to LPS, either priming
otherwise LPS-unresponsive cells (7), allowing a response to subthreshold
amounts of LPS (8), or preventing the decay of LPS-stimulated cytotoxicity (9).
Synergism between LPS and IFN-y has also been observed for the synthesis of
IL-1 in human monocytes (10).
Fibroblasts are widely distributed in the human body. Besides being a source
of IFN-,#, they synthesize C1 (11) and C3 (12), two proteins ofthe complement
system. Thus, fibroblasts may participate in local regulation ofthe inflammatory
response. When stimulated by IFN-y, fibroblasts express MHC class II antigens
(13) and present antigen to lymphocytes (14). IFN-y also increases proliferation
oflung fibroblasts (15).
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In this report we provide data that human fibroblasts synthesized C2 and
factor B constitutively and that this synthesis was modulated by LPS and IFN-y.
Synergism was present between LPS and IFN-y for factor B, but not for C2 .
This synergism was significant only when the two stimuli were present simulta-
neously. LPS and IFN-y each increased rates of protein synthesis and levels of
mRNA for each protein . However, LPS either alone or in combination with
IFN-y induced a greater increase in factor B protein synthesis than in mRNA
levels. These data suggest that LPS acts to increase factor B synthesis at both
pretranslational and translational sites, while IFN-y acts at a pretranslational step
only. The synergism on factor B synthesis was the result of both synergism on
the production of mRNA and an increased efficiency of translation of the newly
produced mRNA.
Materials and Methods
Cells.
￿
Human fibroblast lines were obtained from American Type Culture Collection
(Rockville, MD) (CRL 1471 from the abdomen of a healthy 20-yr-old female and 1507
from the abdomen of a healthy 21-yr-old male), Human Genetic Mutant Cells (NIGMS)
(Camden, NJ) (GM 3440 from the leg of a healthy 20-yr-old male), and Dr. P. M. Henson
(National Jewish Center for Immunology and Respiratory Medicine, Denver, CO) (pri-
mary foreskin). Cells from passages 4 through 8 were used.
Reagents.
￿
Low endotoxin DME and FCS (endotoxin<0. I ng/ml) were purchased from
Hazelton Systems, Inc. (Lenexa, KS). DME without methionine was purchased from Gibco
Laboratories (Chagrin Falls, OH). Streptomycin and L-glutamine were from Flow Labo-
ratories, Inc. (McLean, VA); and albumin bovine crystallized (purity: 98% minimum) was
from Nutritional Biochemicals (Cleveland, OH). This BSA product had the lowest LPS
contamination (0.1 ng/mg) (limulus amebocyte lysate quantitative assay, QCL-1000; M .
A. Bioproducts, Walkersville, MD) of several commercially available preparations tested;
synthesis of complement proteins in cells cultured in medium containing this BSA in
concentrations up to I mg/ml was not different than synthesis in cellscultured in medium
alone. L-[855]Methionine (specific radioactivity, ^-1,000 Ci/mmol), "P-labeled nucleotides
(dCTP, dATP, dGTP, dTTP; specific radioactivity, -667 Ci/mmol), and ENsHANCE
were purchased from New England Nuclear (Boston, MA). Antisera were purchased as
follows: sheep anti-human C2 from Seward Labs (London, England) and Miles Labora-
tories Inc. (Elkhart, IN) and the IgG fraction of goat anti-human factor B from Atlantic
Antibodies (Scarborough, ME). Formalin-fixed Staphylococcus aureus (Cowan strain 2,
IgGsorb) was purchased from The Enzyme Center (Maiden, MA). Recombinant human
IFN-y was kindly provided by Dr. Peter Sorter, Hoffman-La Roche, Inc. (Nutley, NJ) in
0.12 M NaCl, 0.025 M ammonium acetate, pH 5.0, in a concentration of 108 U/ml. The
specific activity of the IFN-y was 1 .9 x 10' IU of antiviral activity per milligram of
protein . IFN-y was diluted in DME containing I mg/ml BSA to a concentration of 108
U/ml for storage at -70°C. LPS, the Westphal extract of Escherichia coli 0111 :114, PMSF,
cycloheximide, and polymyxin B were purchased from Sigma Chemical Co. (St. Louis,
MO). Leupeptin was purchased from Calbiochem-Behring Corp. (LaJolla, CA).
Cell Cultures, Biosynthetic Labeling, and Immunoprecipitation.
￿
Monolayers of human
fibroblasts were grown to confluency in tissue culture multiwell plates in medium contain-
ing 10% FCS (each 2-cm' well contained 1 .5 x 105 cells; three wells were used per
condition). The medium was discarded, the cells were washed twice and cultured for
various time intervals in DME with I mg/ml BSA alone (control) or in media containing
various concentrations of LPS and/or IFN-y. The presence of FCS during the stimulation
period reduced the IFN-y-induced increase in factor B synthesis from approximately six-
to eightfold to two- to threefold. FCS was eliminated during the stimulation period so
that the results would not be affected by the unknown factors present in this serum. Cell
number, determined by counting nuclei (16), was not affected by the concentrations ofKATZ ET AL.
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LPS or IFN-'y that were used. Preliminary experiments demonstrated that constitutive
C2 and factor B synthesis and the response to various stimuli were not dependent on the
degree of confluency. Biosynthetic labeling experiments were performed by incubating
the cells for 2 h in methionine-free DME containing["5S]methionine, 500'lCi/ml (17). At
the end of the pulse period, monolayers were rinsed and either lysed by freeze thawing
(17), or, in pulse-chase experiments, transferred to medium containing 1,000-fold excess
of cold methionine and incubated for varying time periods (chase periods). At the end of
the various periods, extracellular media were harvested and monolayers were lysed. Total
protein synthesis was estimated by incorporation of ["S]methionine into TCA-insoluble
protein (18). Cell lysates and extracellular media were prepared for immunoprecipitation,
preabsorbed with formalin-fixed S. aureus, and immunoprecipitated sequentially for the
relevant proteins (17). Immunoprecipitates were subjected to SDS-PAGE, and the gels
were fixed, impregnated with ENHANCE, dried, and exposed at -70'C to Kodak XAR-
5 film. Incorporation of ["5S]methionine into individual immunoprecipitated proteins was
determined in gel slices after digestion with 15% hydrogen peroxide for 16 h at 600 C
and addition of ScintiVerse II (Fisher Scientific Co., Fair Lawn, NJ).
RNA Extraction, Oligo(dT) Chromatography, and Northern Blot Analysis.
￿
Total cellular
RNA was extracted from monolayers by lysis with guanidium thiocyanate and isolated by
cesium chloride density gradient ultracentrifugation (19). Recovery of RNA from LPS
and/or IFN-y-treated cells and control monolayers was similar. Poly(A)+ RNA was purified
from 100 ;ig total cellular RNA using oligo(dT)-cellulose (type 7; P-L Biochemicals,
Milwaukee, WI), and subjected to Northern blot analysis (6) using double-stranded cDNA
probes radiolabeled with "2P by nick translation . The isolation and characterization of the
cDNA probes for C2 (pC2-2a) (20) and factor B (pBfA28) (21) have been described
previously. The concentration ofcycloheximide used (5,ug/ml) reversibly inhibited protein
synthesis > 90% within 1 h and did not affect the yield of total mRNA after 24 h of
incubation .
Results
C2 and Factor B Synthesis by Human Fibroblasts.
￿
Newly synthesized intracel-
lular and extracellular C2 and factor B proteins were detected in fibroblast
cultures (Fig. 1). Pulse-chase experiments demonstrated precursor-product re-
lationships and kinetics of secretion/catabolism exactly similar to those observed
previously for human monocytes (6), including the two cell-associated forms for
C2 (6, 22) . The two extra bands in the area of 200 kD are unidentified proteins
synthesized by fibroblasts but not by monocytes. These proteins adhered non-
specifically to S. aureus (Fig. 1, lanes A and B): these bands were present when
S. aureus was added without specific antibody, the intensities correlated with the
amount of the S. aureus added and decreased gradually with multiple preclearings
without affecting amounts of C2 or factor B proteins precipitated subsequently
by addition of monospecific antibodies. C2 represented 0.00012% of the TCA-
precipitable protein labeled with ["5S]methionine in the cell lysates and 0 .00068%
in the media. The corresponding values for factor B were 0.00037% and
0 .0014%, respectively.
Effects of LPS and IFN-y on C2 and Factor B Synthesis in Human Fibro-
blasts. Confluent cells were incubated for 24 h in the presence of different
concentrations of LPS or IFN-y before being analyzed for synthesis of C2 and
factor B . While LPS increased synthesis of both factor B and C2, the effects on
factor B (12 .1-fold for 50 ng/ml) were much greater than for C2 (2.1-fold)
(Table 1) . These effects were observed for LPS concentrations as low as 1 ng/ml,
with a maximal response being observed between 50 and 100 ng/ml. The effectsSYNERGISM BETWEEN y INTERFERON AND LIPOPOLYSACCHARIDE
TABLE I
FIGURE 1 .
￿
Synthesis of C2 and factor B by hu-
man fibroblasts . An autoradiograph of SDS-PAGE
analysis under reducing conditions of C2 and fac-
tor B is shown . Human skin fibroblasts were incu-
bated in medium containing 10% FCS until con-
fluent and 4.5 x 10 5 cells were pulse labeled for 2
h in 1 ml of DME without methionine containing
500 uCi [s5S]methionine. Intracellular lysates and
extracellular mediawere precipitated initially with
S . aureus without antibody (A andB) . Subsequently
the same samples were immunoprecipitated se-
quentially with anti-C2 and then anti-factorB and
the products were analyzed by SDS-PAGE and
fluorography . (A and B) Two proteins are dem-
onstrated in the area of 200 kD that adhered
nonspecifically with S . aureus alone . (C and D)
Immunoprecipitates with monospecific antisera to
C2 showed three radiolabeled bands at ^-93, 87,
and 67 kD in the intracellular lysates, and a single
radiolabeled band at -103 kD in the extracellular
media . (F, and F) Immunoprecipitates with mono-
specific antisera to factor B showed single radiola-
beled bands in the intracellular lysates at ^-95 kD
and in the media at -105 kD .
Effect ofLPS andIFN--y on Synthesis of C2 andFactorB
Confluent cultures of human fibroblasts were washed and incubated for 24 h in the presence of
medium containing BSA (1 mg/ml), alone, or with various concentrations of LPS (in ng/ml) or IFN-
y (in U/ml) and pulse labeled as described in legend to Fig . 1 . Areas of SDS-polyacrylamide gels
containing specific C2 and factor B proteins were cut out, digested, and counted after addition of
scintillation fluid . Specific protein counts were corrected for nonspecific background contained in
the appropriate lane of the gel . Data points represent 4-8 different experiments and are expressed
as the ratio of specific protein to total TCA-precipitable protein in the same condition x 106 ± I
SEM.
of LPS on the synthesis of C2 and factor B were not accompanied by changes in
the size or subunit composition of the proteins or their rates of secretion . LPS
concentrations as high as 50 Ag/ml did not affect the number of cells adherent
to the tissue culture plastic or the total synthesis of proteins as measured by
incorporation of [
15S]methionine into TCA-precipitable protein (data not shown) .
LPS C2 Factor B IFN--y C2 Factor B
0 1 .1 ± 0.2 3.7 ± 1 .0 0 1 .1 ± 0.2 3.7 ± 1 .0
1 2.2 ± 0.7 18.3 ± 7.3 1 3.1 ± 2.6 11 .0± 3 .3
10 3.4±1 .2 46.0±17.3 10 5.2 t 1 .6 18 .0± 9.0
50 2.3±0.6 45.0±11 .8 100 7.0±1 .0 26 .4±8 .0
100 0.7±0.9 32.0±11 .0 1,000 11 .6 ± 2.4 57 .0 ± 13.0
500 2.0±0.4 41 .0± 15.3KATZ ET AL.
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IFN-y stimulated comparable increases in C2 (6.3-fold at 100 U/ml) and factor
B (7.1-fold) (Table I). These effects were noted for concentrations as low as 1
U/ml and increased in a concentration-dependent fashion up to 1,000 U/ml.
IFN-y did not affect the number ofcells adherent, total protein synthesis, or the
size or subunit composition of C2 and factor B and their rates ofsecretion.
Because of the possibility that the response to IFN-y was influenced by trace
amounts of LPS contaminating the medium, FCS and BSA, cells were incubated
with polymyxin B for 96 h before and during the stimulation with IFN-y.
Preliminary experiments indicated that 5 ug/ml polymyxin abrogated the re-
sponse of these cells to LPS; i.e., cells incubated with LPS + polymyxin B
synthesized the same amount offactor B as cells incubated in polymyxin B. Cells
in medium containing 5 tag/ml polymyxin B synthesized factor B constitutively
and this synthesis was increased approximately fourfold by 100 U/ml IFN-y.
Thus, the trace amounts of LPS in the medium did not appreciably affect the
function ofthe cells.
Fffect of Simultaneous Incubation with LPS and IFN-y on C2 and Factor B
Synthesis. Since both LPS and IFN-y increased C2 and factor B synthesis when
added to the cells separately, the effects of the combination of the two stimuli
were compared with the additive effects of the individual stimuli. A synergistic
effect was present when the cells that were incubated in both stimuli together
synthesized more protein than would have been predicted from the combined
effects ofthe individual stimuli. A significant synergistic effect wasdemonstrated
for factor B synthesis (2.6-times greater than the combined effects of LPS and
IFN-y when added separately), but not for C2 synthesis (Fig. 2). The rate of
factor B synthesis in the presence of LPS and IFN-y together could not be
achieved by increasing concentrations of, or the times ofincubation with, either
stimulus separately.
To determine if incubation with one stimulus increased the sensitivity of the
cells to the other stimulus, cells were incubated in different combinations of LPS
and IFN-y and synthesis of factor B was quantitated. Synergism was observed
between 100 U/ml IFN-y and concentrations of LPS as low as 1 ng/ml (Fig.
3A). The maximum response to LPS was reached between 10 and 50 ng/ml
whether the cells were incubated in LPS alone or with LPS in combination with
IFN-y (Fig. 3A). Similar results were obtained when the concentrations of IFN-
y were varied while the LPS concentration was constant (Fig. 3B). Synergistic
effects were observed between 50 ng/ml LPS and concentrations of IFN-y as
low as 1 U/ml. The response to IFN-y was concentration dependent up to 1,000
U/ml whether the cells were incubated in IFN-y alone or in combination with
LPS. These results indicated that neither IFN-y nor LPS altered the sensitivity
ofthe cells to the other stimulus .
The time of incubation with the cells required to observe a response was
different with each stimulus. Cells incubated with IFN-y for periods as short as
4 h had an increased capacity to synthesize factor B (2.6-fold) (Fig. 4C). Cells
had to be incubated with LPS at least 12 h for the synthesis of factor B to
increase. Syngergism on factor B synthesis was not noted until the effect ofeach
stimulus was observed independently: the increase in the factor B synthesis in
cells incubated in both stimuli for 4 h was comparable only to the increase with6
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FIGURE 2. Effect of simultaneous incubation with LPS and IFN-y on C2 and factor B
synthesis . Confluentmonolayers were incubated for 24 h in medium containing I mg/mlBSA
alone (control or C) or with 50 ng/ml LPS (L), 100 U/ml IFN-y (I), or LPS + IFN-y (L + I).
Amounts of biosynthetically labeled C2 and factor B in the intracellular lysates for each
condition were determined as described in the legend for Table I . Data points (mean f 1
SEM) represent eight different experiments and are expressed as specific counts divided by
total TCA-precipitable protein in the appropriate experiment . The expected additive effects
(calculated from counts/TCA from Lalone + I alone - I control, dashed bars) were compared
with the actual effects (open bars).
IFN-y alone (2 .5-fold) (Fig . 4, C and D), and a significant synergistic effect was
demonstrated only after 12 h (16-fold increase or 2.5-fold greater than the sum
of the individual effects) (Fig . 4, F-H) .
To determine if thesynergistic response to the twostimuli could be reproduced
by preincubation with one stimulus followed by incubation with the other
stimulus, factor B synthesis was quantitated after two consecutive 18-h periods
ofincubation with thestimuli in varioussequences . Significant synergismbetween
the two stimuli was demonstrated only when both were present together (Fig .
5) . Preincubation with one stimulus did not have a significant effect on the
subsequent response to the other stimulus . For example, preincubation with
IFN-y and subsequent incubation with LPS (Fig . 51) increased factor B synthesis
8.3-fold over control . This response can be compared with the increase for IFN-
y followed by control (6.3-fold ; Fig. 5J) plus the increase for control followed
by LPS (2 .1-fold ; Fig . 5B), or a total of 8 .4 . The 8.3-fold increase in factor B
synthesis with preincubation with IFN-y followed by LPS (Fig . 51) is contrasted
to 45 .2-fold increase in the synthesis of factor B when the cells were incubated
in both stimuli together (Fig. 5K) . Also apparent in Fig. 5 is the persistence of
the effects of LPS, IFN-y, and their combination on factor B synthesis after their
removal (Fig. 5, compare G, J, and L, with A) .
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amounts of poly(A)+ RNA isolated from fibroblasts incubated in the medium
alone or in the different stimuli were subjected to Northern blot analysis using
human cDNA probes for C2 and factor B. The effects of the different stimuli
on amounts ofC2 andfactor B mRNAwereanalyzed with soft laser densitometry.
Both LPS and IFN-,y increased levels of factor B mRNA (Table II). These
increaseswerenotpreventedbyincubation with cycloheximide in concentrations
sufficient to reversibly inhibit protein synthesis by >90% (data not shown),
indicating that new protein synthesis was not required for the effects of these
stimuli on the mRNA levels. LPS induced a greater increase in factor B protein
synthesis than in factor B mRNA, whereas IFN-,y stimulated comparable in-
creases in mRNA and protein (Table II). These data suggest that LPS acts toS
￿
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FIGURE 4 .
￿
Time ofincubation with LPS, IFN-y, and
LPS + IFN-y required to increase the synthesis of
factor B . Confluent fibroblasts were biosynthetically
labeled after incubation with LPS alone, IFN-y alone,
or their combination for periods ranging from 4 to
18 h . Because of the possibility that differences of
total time in culture might affect the capacity of the
cells to synthesize factor B, all cells were pulse labeled
at the same time by varying the times of addition of
the stimuli. The synthesis of factor B was analyzed as
described in legend for Table I .
FIGURE 5 .
￿
Effect of preincubation with one stimulus on the response of the cells to the other
stimulus . Confluent fibroblasts were incubated for two consecutive 18 h periods in varying
combinations of control medium (C), 50 ng/ml LPS (L), 100 U/ml IFN-y (I), or LPS + IFN-
y (L + I) ; in each case mediawere discarded andthe monolayers were rinsed between the two
periods . After the second incubation period the monolayers were biosynthetically labeledand
factorB synthesis in the cell lysates was quantitated as described in the legend to Table I . The
data are the means of two separate experiments and are expressed as the specific counts
divided by total TCA-precipitable protein in the appropriate experiment .TABLE II
Effects ofLPS, IFN-^y, and LPS + IFN-y on Factor B mRNA
KATZ ET AL.
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Fold increase over control
Fibroblasts were incubatedfor 24 hin medium aloneor medium containing LPS
(50 ng/ml), IFN-y (100 U/ml), or LIPS + IFN-y, and total cellular RNA was
extracted using guanidine and cesium chloride density ultracentrifugation. 100
,ug of total cellular RNA for each condition were extracted with oligo(dT) and
subjectedto Northern blot analysis usingcDNA probes forfactor B. Theintensity
andarea of density of therelevant band on the autoradiograms were determined
using soft laser scanning densitometry, and expressed as fold increase over
control.
increase factor B synthesis at both pretranslational and translational sites, while
IFN-y acts primarily at a pretranslational step. LPS and IFN-y together induced
an ^-36.7-fold increase in factor B mRNA over control, which was 3.5-fold
greaterthan predicted from the increase when the stimuli were added separately,
comparable to the synergistic effect (2.8-fold) on protein synthesis (Table II).
LPS increased C2 mRNA 2.5-fold (data not shown), similar to the increase in
factor B mRNA, but the increase in C2 protein synthesis was only 2.0-fold. For
IFN-y, increases in C2 mRNA (6.4-fold) and protein synthesis (6.4-fold) were
comparable, similar to the results for factor B. As with the protein data, there
was no synergism between LPS and IFN-y for C2 mRNA. Cycloheximide in
concentrations that reversibly inhibited protein synthesis did not prevent the
increases in levels of factor B or C2 mRNA in response to LPS, IFN-y, or their
combination.
Discussion
We report that human fibroblasts synthesize C2 and factor B and that this
synthesis is regulated by LPS and IFN-y. The size and subunit structure of C2
and factor B produced in human fibroblasts were similar to that observed in
both Hep-G2 cells (22, 23)and in human monocytes (6). Unstimulated fibroblasts
and monocytes synthesized approximately comparable amounts offactor B per
cell; however, monocytes synthesized ^-100-fold more C2 per cell than fibroblasts
(24).
IFN-y increased synthesis of both proteins, but LPS had a significant effect
only on synthesis of factor B. This pattern and the levels of stimulation of C2
and factor B were comparable to those observed with these stimuli in monocytes
(6, 24). The molecular mechanisms underlying these effects, as reflected in the
relationships between rates of protein synthesis and levels of mRNA, were
different for the two stimuli. For :IFN-y, increases in rates ofprotein synthesis
and mRNA levels were comparable for both C2 and factor B, suggesting that
IFN-y affects both C2 and factor B synthesis at a pretranslational level. For LPS,
Treatment
Exp.
1
Factor B
Exp.
2
mRNA
Exp.
3
levels
Exp. 4
Mean
Mean
for
protein
LPS 4.0 1.2 3.7 1.9 2.7 12.1
IFN 1.9 6.1 4.0 15.5 6.9 7.1
LPS + IFN 24 8.1 13 .8 101 36.7 54.510
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the increase in the rate of factor B protein synthesis was much greater than for
factor B mRNA; the small increase in the rate of C2 protein synthesis was
accompanied by a comparable increase in C2 mRNA. These results suggest that
the major effect of LPS (on factor B synthesis) occurs at the translational level.
The absence of a significant effect of LPS on C2 synthesis may be due to the
absence oftranslational regulation for the C2 mRNA .
Translational regulatory events also occur for the mechanism ofaction of LPS
on the synthesis ofcachectin,orTNF (25). Mouse macrophagescontainedmRNA
for TNF, but did not synthesize TNF protein until stimulated with LPS. The
events that govern these effects are not known, but it has been speculated that
they may be related to an octameric sequence (UUAUUUAU) present in the 3'
untranslated region of the mRNA (26). This sequence is also present in the 3'
untranslated regions of other inflammatory mediators that respond to LPS (27).
The factor B gene does not contain this octameric sequence through 100
nucleotides 3' to the stop codon region (28), but the sequence is found between
100 and 200 nucleotides 3' to the untranslated region ofthe other genes.
The combination of LPS and IFN-y had a significant synergistic effect on the
synthesis of factor B. Synergism may be dependent, at least in part, on LPS-
induced translational regulation of factor B mRNA. Synergism was observed
only after the cells had been incubated for periods long enough to produce an
effect of LPS alone and did not occur after periods of incubation when only
IFN-y increased factor B synthesis. And there was no synergism for C2, for
which only the transcriptional effect of LPS was observed. The wide scatter of
the data points for mRNA levels prevents a definitive assignment ofthe level of
the synergistic effect. Synergism was also evident for factor B mRNA levels,
suggesting that pretranslational steps may also be affected synergistically. There
was no synergism for C2 mRNA levels.
Synergism between LPS and IFN-y has been studied in several cell types with
different cell functions as the marker ofthe effect. Most studies ofthe combined
effects of LPS and IFN-y have examined complex cell functions. In the only
study demonstrating synergism for a single protein product of a cell (IL-1), the
mechanism of synergism was not investigated (10). Synergism has been studied
most for tumor cell killing in macrophages, where IFN-y either increased the
sensitivity of the cells to LPS (29), allowed an otherwise unresponsive cell to
respond to the LPS (30), or prevented the decay of LPS-induced cytotoxicity
that occurs in some cells even in the continued presence of LPS (9, 31). The
effect of IFN-y on LPS action was observed whether the IFN-y increased killing
when added by itself (8) or not (29). IFN-y prevented the decay of LPS-induced
cytotoxicity either by preventing a negative feedback of PGE2 (9, 31) or by
maintaining production of a soluble cytotoxic factor that otherwise decreased
with time in culture (32). Another possible mechanism ofthe effect of IFN-y on
LPS action is increasing the bindingof LPS to the cell surface (30). It is unlikely
that the mechanisms proposed for synergism in these other systems account for
synergism on factor B synthesis: preventing the negative feedback of PGE2 is
unlikely since the effect of LPS on fibroblasts did not decay with continued
incubation with LPS through 48 h and addition ofPGE2 to the cultures did not
abolish the LPS-induced stimulation (Katz, Y., and R. C. Strunk, unpublishedKATZ ET AL.
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observations). Increased binding of LPS to the cell surface is unlikely because
the effects of the combination of even low concentrations of the two stimuli
could not be reproduced by simply increasing the concentrations of LPS (Fig. 3,
A and B).
The role of IFN-y in regulation of TNF synthesis was different from its role
in regulation of factor B synthesis. IFN-y by itself did not stimulate TNF
production. In addition, IFN-y did not increase the LPS-induced stimulation of
TNF production in normal cells. However, in cells resistant to the effects of LPS
(C3H/Hej), IFN-yallowed translationofotherwise nonfunctioning TNFmRNA,
amounts of which had been stimulated by LPS (33). The mechanism of interac-
tion between LPS and IFN-y in normal fibroblasts observed in our study is
probably distinct from the mechanism in these otherwise LPS-unresponsive cells.
Synergism between LPS and IFN-y for synthesis of factor B required close
interaction between the two stimuli, as evidenced by the absence ofan effect of
preincubation with one stimulus on the subsequent response to the other stimu-
lus. This was true even though the effect ofthe first stimulus persisted during
the stimulation with the second compound. These observations are in contrast
to the other systems where the enhancing effects of IFN-y were reproduced by
preincubation of the cells with IFN-y alone, followed by incubation of LPS in
the absence of IFN-y (15, 30, 34). IFN-y priming of the cells for the increased
response to LPS in these other systems was seen as early as 4 h after addition of
the IFN-y (15, 29).
The major protein products offibroblasts are collagen, elastin, proteoglycans,
and glycoproteins (35). Synthesis ofproteins ofthe complement pathway C1 (11)
and C3 (12) in these cells has also been documented. Synthesis of C2 and factor
B in human fibroblasts may play a role in host defense. Fibroblasts are abundant
in many tissues and synthesis by fibroblasts would provide complement proteins
for participation in inflammatory reactions before increases in vascular permea-
bility and recruitment ofother complement producing inflammatory cells. Em-
phasis on synthesis of factor B over C2, both constitutively and in response to
endotoxin, is consistent with the concept that the alternative pathway has a
significant role in the initial response to inflammation at local sites before the
availability ofantibody.
Summary
Four different human fibroblast cell lines synthesized C2 and factor B. Factor
B synthesis was increased 12.1-fold by 50 ng/ml LPS and 7.1-fold by 100 U/ml
IFN-y. C2 synthesis was increased only 2.1-fold by LPS, but 6.4-fold by IFN-y.
Both LPS and IFN-y increased levels of factor B mRNA. LPS induced a 4.7-fold
greater increase in factor B protein than in factor B mRNA, whereas IFN-y
stimulated comparable increases in protein and mRNA. These data suggest that
LPS acts to increase factor B synthesis at both pretranslational and translational
sites, while IFN-y acts primarily at a pretranslational level. In contrast to factor
B, increases in C2 protein and C2 mRNA were comparable for both stimuli. A
synergisticeffect between the two stimuli was observed for factor B only: protein
synthesis was increased 54.5-fold or 2.8-fold greater than the additive effects of
the stimuli separately. The rate of synthesis in the presence of LPS and IFN-y1 2
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together could not be achieved by increasing concentrations of, or the times of
incubation with, either stimulus separately. The synergism was not the result of
an increased sensitivity ofthe cells to either stimulus and was not reproduced by
preincubation with one stimulus before incubation with the other stimulus.
Several lines ofevidence suggest that the synergism, like the stimulation offactor
B synthesis by LPS, was dependent on both translational and pretranslational
regulation offactor B mRNA. C2 and factor B synthesized in human fibroblasts
may play a role in host defense in inflammatory reactions before increases in
vascular permeability and recruitment ofother complement producing cells.
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